ATE372121T1 - Nicht fermentiertes gelanteil aus samenhülsen von psyllium - Google Patents
Nicht fermentiertes gelanteil aus samenhülsen von psylliumInfo
- Publication number
- ATE372121T1 ATE372121T1 AT00941266T AT00941266T ATE372121T1 AT E372121 T1 ATE372121 T1 AT E372121T1 AT 00941266 T AT00941266 T AT 00941266T AT 00941266 T AT00941266 T AT 00941266T AT E372121 T1 ATE372121 T1 AT E372121T1
- Authority
- AT
- Austria
- Prior art keywords
- psyllium seed
- seed hulls
- gel portion
- gel
- fermented
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Pretreatment Of Seeds And Plants (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/328,611 US6287609B1 (en) | 1999-06-09 | 1999-06-09 | Unfermented gel fraction from psyllium seed husks |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE372121T1 true ATE372121T1 (de) | 2007-09-15 |
Family
ID=23281664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00941266T ATE372121T1 (de) | 1999-06-09 | 2000-06-08 | Nicht fermentiertes gelanteil aus samenhülsen von psyllium |
Country Status (12)
Country | Link |
---|---|
US (2) | US6287609B1 (de) |
EP (1) | EP1189621B1 (de) |
JP (2) | JP4034564B2 (de) |
CN (2) | CN101219165A (de) |
AT (1) | ATE372121T1 (de) |
AU (1) | AU773580B2 (de) |
CA (1) | CA2376326C (de) |
DE (1) | DE60036282T2 (de) |
HK (1) | HK1044718B (de) |
MX (1) | MXPA01012581A (de) |
RU (2) | RU2261102C2 (de) |
WO (1) | WO2000074689A1 (de) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6946152B1 (en) | 1999-06-09 | 2005-09-20 | Wisconsin Alumni Research Foundation | Unfermented gel fraction from psyllium seed husks |
US6287609B1 (en) | 1999-06-09 | 2001-09-11 | Wisconsin Alumni Research Foundation | Unfermented gel fraction from psyllium seed husks |
ATE410075T1 (de) * | 2000-10-13 | 2008-10-15 | E Z Em Inc | Ernährungssystem, formulierung, set und methode zur verwendung bei der vorbereitung einer person für eine bestimmte tätigkeit |
EG26979A (en) * | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
GB0121621D0 (en) * | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
ATE349214T1 (de) | 2001-09-08 | 2007-01-15 | Astrazeneca Ab | Benzothiazepin und benzothiadiazepin derivative mit hemmender wirkung auf den säuretransport in den gallengängen zur behandlung von hyperlipidaemia |
US7195789B2 (en) * | 2002-03-07 | 2007-03-27 | Board Of Trustees Of Michigan State University | Non-fiber extract of psyllium with anti-tumorigenic effects and method for identifying the same |
US11103542B2 (en) | 2002-03-13 | 2021-08-31 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
US20050074442A1 (en) | 2002-03-13 | 2005-04-07 | Natarajan Ranganathan | Compositions and methods for augmenting kidney function |
US9980988B2 (en) | 2002-03-13 | 2018-05-29 | Kibow Biotech, Inc. | Compositions and methods for augmenting kidney function |
US9655932B2 (en) | 2002-03-13 | 2017-05-23 | Kibow Biotech, Inc. | Composition and method for preventing or treating gout or hyperuricemia |
JP2003278418A (ja) * | 2002-03-22 | 2003-10-02 | Denso Corp | 車載無線機装置 |
GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
US20030215534A1 (en) * | 2002-05-20 | 2003-11-20 | The Procter & Gamble Company | Extraction of unmilled psyllium |
US7014862B2 (en) * | 2002-05-20 | 2006-03-21 | The Procter & Gamble Company | Chewable compositions containing a gel-forming extract of psyllium |
US20050042307A1 (en) * | 2002-05-21 | 2005-02-24 | Marlett Judith A. | Gel-forming polysaccharide from psyllium seed husks |
GB0213669D0 (en) * | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
GB0216321D0 (en) * | 2002-07-13 | 2002-08-21 | Astrazeneca Ab | Therapeutic treatment |
US7098193B2 (en) * | 2003-02-18 | 2006-08-29 | The Procter & Gamble Company | Compositions comprising a defined polysaccharide component |
US6982254B2 (en) * | 2003-02-18 | 2006-01-03 | The Procter & Gamble Company | Compositions comprising a plurality of particles or agglomerates having a defined particle size |
US7026303B2 (en) * | 2003-02-18 | 2006-04-11 | The Procter & Gamble Company | Compositions comprising a polysaccharide component and one or more coating layers |
US20040161471A1 (en) * | 2003-02-18 | 2004-08-19 | Cimiluca Paul Alfred | Compositions comprising a plurality of particles or agglomerates having a defined particle size |
GB0304194D0 (en) * | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
GB0307918D0 (en) * | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
AU2008202120B2 (en) * | 2003-04-05 | 2009-12-17 | Albireo Ab | Use of an IBAT inhibitor for the treatment of prophylaxis of constipation |
US20050250734A1 (en) * | 2003-11-07 | 2005-11-10 | The Procter & Gamble Company | Compositions, kits, and methods for the treatment of conditions associated with elevated cholesterol levels |
US7106595B2 (en) * | 2004-09-15 | 2006-09-12 | International Business Machines Corporation | Apparatus including a thermal bus on a circuit board for cooling components on a daughter card releasably attached to the circuit board |
US20060165824A1 (en) * | 2005-01-26 | 2006-07-27 | The Procter & Gamble Company | Compositions, kits, and methods for enhancing gastrointestinal health |
US9420807B2 (en) | 2007-04-02 | 2016-08-23 | Purina Animal Nutrition Llc | Method of feeding young monogastric mammals and composition fed to young monogastric mammals |
US20080293670A1 (en) * | 2007-05-23 | 2008-11-27 | Agricultural Research Institute | Edible tremella polysaccharide for prevention and/or improvement of intestinal disorder |
JP5390091B2 (ja) * | 2007-12-05 | 2014-01-15 | 矢崎総業株式会社 | コネクタ |
KR20200111230A (ko) | 2008-12-31 | 2020-09-28 | 알데릭스, 인코포레이티드 | 체액 저류 또는 염 과부하와 연관된 장애 및 위장관 장애의 치료 시에 nhe-매개된 역수송을 억제하는 화합물 및 방법 |
WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US20100278949A1 (en) * | 2009-05-01 | 2010-11-04 | Jeffery Dale Scott | Pre-procedure meal regimen |
SG190029A1 (en) | 2010-11-08 | 2013-06-28 | Albireo Ab | Ibat inhibitors for the treatment of liver diseases |
US20150336892A1 (en) | 2012-08-21 | 2015-11-26 | Ardelyx, Inc | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
KR102287207B1 (ko) | 2013-04-12 | 2021-08-09 | 알데릭스, 인코포레이티드 | Nhe3-결합 화합물 및 포스페이트 수송을 저해하는 방법 |
JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
WO2015199147A1 (ja) | 2014-06-25 | 2015-12-30 | 味の素株式会社 | 固形製剤及びその着色防止又は着色低減方法 |
EP3012252A1 (de) | 2014-10-24 | 2016-04-27 | Ferring BV | Kristalline Form von elobixibat |
US10226063B2 (en) | 2015-10-01 | 2019-03-12 | The United States Of America As Represented By The Secretary Of Agriculture | Methods of decreasing the viscosity of a dietary fiber |
US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
WO2018125735A1 (en) | 2016-12-29 | 2018-07-05 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
CN110291082A (zh) | 2017-01-09 | 2019-09-27 | 阿德利克斯股份有限公司 | Nhe介导的反向转运的抑制剂 |
EP3565808A1 (de) | 2017-01-09 | 2019-11-13 | Ardelyx, Inc. | Verbindungen zur behandlung erkrankungen des magen-darm-traktes |
CA3071285A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | Cholestyramine granules, oral cholestyramine formulations and use thereof |
TW202015699A (zh) | 2018-06-05 | 2020-05-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途 |
US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
WO2019245449A1 (en) | 2018-06-20 | 2019-12-26 | Albireo Ab | Pharmaceutical formulation of odevixibat |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
EP4069361B1 (de) | 2019-12-04 | 2024-01-03 | Albireo AB | Benzothia(di)azepinverbindungen und ihre verwendung als gallensäuremodulatoren |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
EP4069247A1 (de) | 2019-12-04 | 2022-10-12 | Albireo AB | Benzothiadiazepinverbindungen und ihre verwendung als gallensäuremodulatoren |
JP2023504647A (ja) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
FI4069360T3 (fi) | 2019-12-04 | 2024-02-20 | Albireo Ab | Bentsotia(di)atsepiinin yhdisteet ja niiden käyttö sappihapon modulaattoreina |
CN116157389A (zh) | 2020-08-03 | 2023-05-23 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
CA3196488A1 (en) | 2020-11-12 | 2022-05-19 | Albireo Ab | Odevixibat for treating progressive familial intrahepatic cholestasis (pfic) |
JP2024500309A (ja) | 2020-12-04 | 2024-01-09 | アルビレオ エービー | ベンゾチア(ジ)アゼピン化合物および胆汁酸モジュレータとしてのその使用 |
CN114343099B (zh) * | 2022-01-11 | 2024-03-26 | 山东中大药业有限公司 | 一种l-阿拉伯糖膳食纤维固体饮料及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX168010B (es) * | 1987-01-06 | 1993-04-28 | Felipe Salete | Procedimiento mejorado para la obtencion de mucilago de plantogo psyllium de alta pureza |
US5248502A (en) * | 1991-11-08 | 1993-09-28 | Kellogg Company | Method for decreasing the allergenicity of psyllium seed husk by alkaline treatment |
US5234916A (en) * | 1992-06-12 | 1993-08-10 | The Proctor & Gamble Company | Psyllium drink mix compositions |
US6287609B1 (en) | 1999-06-09 | 2001-09-11 | Wisconsin Alumni Research Foundation | Unfermented gel fraction from psyllium seed husks |
-
1999
- 1999-06-09 US US09/328,611 patent/US6287609B1/en not_active Expired - Lifetime
-
2000
- 2000-06-08 AT AT00941266T patent/ATE372121T1/de not_active IP Right Cessation
- 2000-06-08 WO PCT/US2000/015693 patent/WO2000074689A1/en active IP Right Grant
- 2000-06-08 EP EP00941266A patent/EP1189621B1/de not_active Expired - Lifetime
- 2000-06-08 RU RU2002100090/15A patent/RU2261102C2/ru not_active IP Right Cessation
- 2000-06-08 CA CA2376326A patent/CA2376326C/en not_active Expired - Fee Related
- 2000-06-08 DE DE60036282T patent/DE60036282T2/de not_active Expired - Fee Related
- 2000-06-08 CN CNA2007101887205A patent/CN101219165A/zh active Pending
- 2000-06-08 MX MXPA01012581A patent/MXPA01012581A/es active IP Right Grant
- 2000-06-08 JP JP2001512329A patent/JP4034564B2/ja not_active Expired - Fee Related
- 2000-06-08 CN CNB008110409A patent/CN100360136C/zh not_active Expired - Fee Related
- 2000-06-08 AU AU55994/00A patent/AU773580B2/en not_active Ceased
-
2001
- 2001-09-10 US US09/949,561 patent/US6676979B2/en not_active Expired - Fee Related
-
2002
- 2002-08-28 HK HK02106343.9A patent/HK1044718B/zh not_active IP Right Cessation
-
2005
- 2005-01-28 RU RU2005102049/15A patent/RU2314114C2/ru not_active IP Right Cessation
-
2007
- 2007-08-28 JP JP2007220766A patent/JP2008013575A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE60036282D1 (de) | 2007-10-18 |
EP1189621B1 (de) | 2007-09-05 |
HK1044718B (zh) | 2008-04-25 |
JP2003505436A (ja) | 2003-02-12 |
MXPA01012581A (es) | 2002-04-10 |
RU2005102049A (ru) | 2006-07-10 |
US6287609B1 (en) | 2001-09-11 |
CN101219165A (zh) | 2008-07-16 |
CN100360136C (zh) | 2008-01-09 |
HK1044718A1 (en) | 2002-11-01 |
EP1189621A4 (de) | 2004-05-26 |
CA2376326A1 (en) | 2000-12-14 |
AU773580B2 (en) | 2004-05-27 |
JP2008013575A (ja) | 2008-01-24 |
DE60036282T2 (de) | 2008-06-05 |
US6676979B2 (en) | 2004-01-13 |
EP1189621A1 (de) | 2002-03-27 |
US20020142054A1 (en) | 2002-10-03 |
WO2000074689A8 (en) | 2001-06-21 |
CN1365283A (zh) | 2002-08-21 |
JP4034564B2 (ja) | 2008-01-16 |
AU5599400A (en) | 2000-12-28 |
CA2376326C (en) | 2011-03-15 |
RU2261102C2 (ru) | 2005-09-27 |
RU2314114C2 (ru) | 2008-01-10 |
WO2000074689A1 (en) | 2000-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE372121T1 (de) | Nicht fermentiertes gelanteil aus samenhülsen von psyllium | |
DE60010098D1 (de) | 28-epirapaloge | |
DE69801048D1 (de) | Fungizide trifluorophenyl-triazolopyrimidine | |
CA2199117A1 (en) | Compounds and methods for the treatment of cancer | |
HN1996000017A (es) | Isotiazolonas | |
TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
MA24643A1 (fr) | Tetrahydro-naphtalenes substitues et composes analogues | |
ATE255153T1 (de) | Integriertes lösungsmittelentasphaltierungs- , vergasungs- und wasserstoffbehandlungsverfahren | |
DE69826684D1 (de) | Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen | |
DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
NO964238L (no) | Halofantrin-fri-base for behandling av malaria og blandinger | |
DE69810521D1 (de) | Abbeizzusammensetzungen, ihre Herstellung und Verwendung | |
AU4996100A (en) | (s,r) formoterol methods and compositions | |
PT1204659E (pt) | Benzofuranos serotoninergicos | |
ITMI20000665A0 (it) | Glicosaminoglicani derivati dal polisaccaride k5 aventi elevata attivita' anticoagulante ed antitrombotica e processo per la loro preparazio | |
BRPI0415285A (pt) | derivados de aminoalcanol | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
ATE235158T1 (de) | Nicht klebende weiche süsswaren-zusammensetzung und methoden zu dessen herstellung | |
SI1244614T1 (en) | Tryptase inhibitors | |
BR9606955A (pt) | Heterocicloalquenos substituísos | |
EP1574507A3 (de) | Furo- und Pyrano-Naphthochinone und ihre Verwendung gegen Krebs | |
ID27733A (id) | Metoksiminofenilasetamida | |
DE50003587D1 (de) | Verbundelemente | |
ATE305785T1 (de) | Cd45 hemmer | |
HK1049485A1 (en) | DithiepinoÄ6,5-BÜpyridines, and related compositions, methods of producing and uses. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |